During the past decade, AZ Klina conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 23 clinical trials were completed, i.e. on average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 18 clinical trials were completed. i.e. 51.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Klina" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "University Hospital, Antwerp" with 10 trials sponsored, "Celgene" with 8 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Klina" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "AZ Klina" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "Kom Op Tegen Kanker" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "AZ Klina" are "Breast Cancer" (8 trials), "Crohn Disease" (4 trials), "Myelodysplastic Syndromes" (4 trials), "Metastatic Breast Cancer" (3 trials) and "Myelodysplastic Syndrome" (3 trials). Many other conditions were trialed in "AZ Klina" in a lesser frequency.

Most popular intervention types in "AZ Klina" are "Drug" (65 trials), "Other" (15 trials), "Procedure" (7 trials), "Biological" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Paclitaxel" (7 trials), "Carboplatin" (6 trials), "Cisplatin" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "AZ Klina" are 74 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "AZ Klina". undefined are not yet recruiting, 28 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in AZ Klina, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Klina, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 11 trials that are defined as “Not Applicable".